These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 12391224

  • 1. Modulation of gene expression by the MHC class II transactivator.
    Nagarajan UM, Bushey A, Boss JM.
    J Immunol; 2002 Nov 01; 169(9):5078-88. PubMed ID: 12391224
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A, Takahashi M, Toba K, Zheng Z, Hashimoto S, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    Hematol Oncol; 1999 Dec 01; 17(4):149-60. PubMed ID: 10725870
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
    Kanaseki T, Ikeda H, Takamura Y, Toyota M, Hirohashi Y, Tokino T, Himi T, Sato N.
    J Immunol; 2003 May 15; 170(10):4980-5. PubMed ID: 12734341
    [Abstract] [Full Text] [Related]

  • 4. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
    Taxman DJ, Cressman DE, Ting JP.
    J Immunol; 2000 Aug 01; 165(3):1410-6. PubMed ID: 10903745
    [Abstract] [Full Text] [Related]

  • 5. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
    Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B.
    Science; 1994 Jul 01; 265(5168):106-9. PubMed ID: 8016643
    [Abstract] [Full Text] [Related]

  • 6. DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.
    Murphy SP, Holtz R, Lewandowski N, Tomasi TB, Fuji H.
    J Immunol; 2002 Sep 15; 169(6):3085-93. PubMed ID: 12218125
    [Abstract] [Full Text] [Related]

  • 7. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, Bolick SC, Wright KL.
    Mol Immunol; 2006 Feb 15; 43(6):519-28. PubMed ID: 15950283
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.
    Lee YJ, Han Y, Lu HT, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN.
    J Immunol; 1997 Mar 01; 158(5):2065-75. PubMed ID: 9036950
    [Abstract] [Full Text] [Related]

  • 9. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M, Flynt FL, Hong M, Chen H, Gilbert CA, Briley NT, Bolick SC, Wright KL, Piskurich JF.
    Mol Immunol; 2007 Apr 01; 44(11):2923-32. PubMed ID: 17300840
    [Abstract] [Full Text] [Related]

  • 10. Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.
    Deffrennes V, Vedrenne J, Stolzenberg MC, Piskurich J, Barbieri G, Ting JP, Charron D, Alcaïde-Loridan C.
    J Immunol; 2001 Jul 01; 167(1):98-106. PubMed ID: 11418637
    [Abstract] [Full Text] [Related]

  • 11. Class II transactivator is required for maximal expression of HLA-DOB in B cells.
    Nagarajan UM, Lochamy J, Chen X, Beresford GW, Nilsen R, Jensen PE, Boss JM.
    J Immunol; 2002 Feb 15; 168(4):1780-6. PubMed ID: 11823510
    [Abstract] [Full Text] [Related]

  • 12. Induction of MHC class I expression by the MHC class II transactivator CIITA.
    Martin BK, Chin KC, Olsen JC, Skinner CA, Dey A, Ozato K, Ting JP.
    Immunity; 1997 May 15; 6(5):591-600. PubMed ID: 9175837
    [Abstract] [Full Text] [Related]

  • 13. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y, Toyota M, Satoh A, Murai M, Mita H, Suzuki H, Takamura Y, Ikeda H, Ishida T, Sato N, Tokino T, Imai K.
    Br J Cancer; 2004 Feb 23; 90(4):844-52. PubMed ID: 14970863
    [Abstract] [Full Text] [Related]

  • 14. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M, Whiteside TL, Kaufmann R, Seliger B.
    Arch Dermatol Res; 2009 Feb 23; 301(2):189-93. PubMed ID: 19104823
    [Abstract] [Full Text] [Related]

  • 15. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
    Pai RK, Askew D, Boom WH, Harding CV.
    J Immunol; 2002 Aug 01; 169(3):1326-33. PubMed ID: 12133955
    [Abstract] [Full Text] [Related]

  • 16. Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
    Chang CH, Flavell RA.
    J Exp Med; 1995 Feb 01; 181(2):765-7. PubMed ID: 7836928
    [Abstract] [Full Text] [Related]

  • 17. Quantitative control of MHC class II expression by the transactivator CIITA.
    Otten LA, Steimle V, Bontron S, Mach B.
    Eur J Immunol; 1998 Feb 01; 28(2):473-8. PubMed ID: 9521055
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M, Jager M, Ono SJ.
    Exp Mol Pathol; 2007 Feb 01; 82(1):68-76. PubMed ID: 16650406
    [Abstract] [Full Text] [Related]

  • 19. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM.
    J Exp Med; 1995 Nov 01; 182(5):1517-25. PubMed ID: 7595221
    [Abstract] [Full Text] [Related]

  • 20. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
    Scholl T, Mahanta SK, Strominger JL.
    Proc Natl Acad Sci U S A; 1997 Jun 10; 94(12):6330-4. PubMed ID: 9177217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.